Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects
NCT02897726Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Mar 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NVP-1402 in hypercholesterolemia (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Maximum Plasma Concentration at 24 hours and Area Under the Curve to the last measurable concentration at 24 hours. Started Mar 2017; status: completed.
02
Drugs
NVP-1402
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02897726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897726.